
House Committee Probes Pharmaceutical Companies Over China Drug Trials
A House committee has launched an investigation into several pharmaceutical companies, including Eli Lilly, Bristol, Merck, and AbbVie, regarding their clinical trials in China, particularly those tied to military-linked hospitals and facilities in Xinjiang, citing biotech risks.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)Sources
Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals
House committee launches investigation into Eli Lilly's China clinical trials at military hospitals and Xinjiang facilities, citing biotech risks.
Read full article →


